Christian Rabaud

4.4k total citations
104 papers, 2.1k citations indexed

About

Christian Rabaud is a scholar working on Epidemiology, Infectious Diseases and Applied Microbiology and Biotechnology. According to data from OpenAlex, Christian Rabaud has authored 104 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Epidemiology, 47 papers in Infectious Diseases and 26 papers in Applied Microbiology and Biotechnology. Recurrent topics in Christian Rabaud's work include Antibiotic Use and Resistance (26 papers), Pneumocystis jirovecii pneumonia detection and treatment (12 papers) and HIV/AIDS drug development and treatment (12 papers). Christian Rabaud is often cited by papers focused on Antibiotic Use and Resistance (26 papers), Pneumocystis jirovecii pneumonia detection and treatment (12 papers) and HIV/AIDS drug development and treatment (12 papers). Christian Rabaud collaborates with scholars based in France, Italy and Canada. Christian Rabaud's co-authors include Dominique Costagliola, Thierry May, Alain Lozniewski, Murielle Mary‐Krause, P Canton, H. Schuhmacher, Catherine Chirouze, Bruno Hoen, Isabelle Poizot‐Martin and Hervé Tissot‐Dupont and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Christian Rabaud

100 papers receiving 2.0k citations

Peers

Christian Rabaud
Shirish Huprikar United States
Ji Hwan Bang South Korea
Joon‐Sup Yeom South Korea
Glenn Wortmann United States
Shirish Huprikar United States
Christian Rabaud
Citations per year, relative to Christian Rabaud Christian Rabaud (= 1×) peers Shirish Huprikar

Countries citing papers authored by Christian Rabaud

Since Specialization
Citations

This map shows the geographic impact of Christian Rabaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Rabaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Rabaud more than expected).

Fields of papers citing papers by Christian Rabaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Rabaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Rabaud. The network helps show where Christian Rabaud may publish in the future.

Co-authorship network of co-authors of Christian Rabaud

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Rabaud. A scholar is included among the top collaborators of Christian Rabaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Rabaud. Christian Rabaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olivera, Pablo A., Juan S. Lasa, Vipul Jairath, et al.. (2022). Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Crohn s and Colitis. 17(2). 199–210. 5 indexed citations
2.
3.
D’Amico, Ferdinando, Christian Rabaud, Laurent Peyrin‐Biroulet, & Silvio Danese. (2021). SARS-CoV-2 vaccination in IBD: more pros than cons. Nature Reviews Gastroenterology & Hepatology. 18(4). 211–213. 29 indexed citations
4.
Robineau, Olivier, J. Robert, Christian Rabaud, et al.. (2018). Management and outcome of bloodstream infections: a prospective survey in 121 French hospitals (SPA-BACT survey). Infection and Drug Resistance. Volume 11. 1359–1368. 22 indexed citations
5.
Robert, J., Y. Péan, S. Alfandari, et al.. (2017). Application of guidelines for aminoglycosides use in French hospitals in 2013–2014. European Journal of Clinical Microbiology & Infectious Diseases. 36(7). 1083–1090. 7 indexed citations
6.
Alfandari, S., J. Robert, Y. Péan, et al.. (2015). Antibiotic use and good practice in 314 French hospitals: The 2010 SPA2 prevalence study. Médecine et Maladies Infectieuses. 45(11-12). 475–480. 16 indexed citations
7.
Ambert‐Balay, Katia, A. Mosnier, Serge Aho, et al.. (2015). Burden of gastroenteritis outbreaks: specific epidemiology in a cohort of institutions caring for dependent people. Journal of Hospital Infection. 91(1). 19–27. 6 indexed citations
8.
Hansmann, Yves, Nicolas Lefèbvre, Matthieu Revest, et al.. (2014). Feedback on difficulties raised by the interpretation of serological tests for the diagnosis of Lyme disease. Médecine et Maladies Infectieuses. 44(5). 199–205. 9 indexed citations
9.
Piroth, Lionel, A. Péchinot, Vincent Di Martino, et al.. (2014). Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis: a two-year observational study. BMC Infectious Diseases. 14(1). 287–287. 48 indexed citations
10.
May, T., et al.. (2012). Antibiolor, the Lorraine antibiology network: Update on 7 years of activity. Médecine et Maladies Infectieuses. 42(8). 355–360. 3 indexed citations
11.
Doco‐Lecompte, Thanh, et al.. (2012). Relevance of fluoroquinolone use in a French teaching hospital. Médecine et Maladies Infectieuses. 42(12). 608–614. 1 indexed citations
12.
Pellissier, Gérard, et al.. (2012). Effectiveness of respirator masks for healthcare workers, in France. Médecine et Maladies Infectieuses. 42(6). 264–269. 21 indexed citations
13.
Alfandari, S., et al.. (2012). Staphylococcus aureus nasal carriage during the infectious diseases national congress in France. Médecine et Maladies Infectieuses. 42(9). 435–439. 5 indexed citations
14.
Jeulin, Hélène, et al.. (2009). Occult hepatitis B infection in patients infected with HIV: Report of two cases of hepatitis B reactivation and prevalence in a hospital cohort. Journal of Medical Virology. 82(2). 206–212. 24 indexed citations
15.
Binquet, Christine, Gwénaël Le Teuff, Amel Mahboubi, et al.. (2009). Markov modelling of HIV infection evolution in the HAART era. Epidemiology and Infection. 137(9). 1272–1282. 7 indexed citations
16.
Grabar, Sophie, Émilie Lanoy, Clotilde Allavena, et al.. (2008). Causes of the first AIDS‐defining illness and subsequent survival before and after the advent of combined antiretroviral therapy*. HIV Medicine. 9(4). 246–256. 50 indexed citations
17.
Lecompte, Thibaut, et al.. (2005). Création d'un réseau ville-hôpital en antibiologie : ANTIBIOLOR. Médecine et Maladies Infectieuses. 35. S137–S139. 1 indexed citations
18.
Rabaud, Christian, et al.. (2001). Infection and/or colonization by methicillin-resistant Staphylococcus epidermidis (MRSE). Pathologie Biologie. 49(10). 812–814. 9 indexed citations
19.
Rabaud, Christian, et al.. (1998). Estudio del comportamiento del personal hospitalario respecto a los accidentes con exposición a sangre. Medicina y Seguridad del Trabajo. 45(176). 1001–1014.
20.
Hoen, Bruno, I. Béguinot, Christian Rabaud, et al.. (1996). The Duke Criteria for Diagnosing Infective Endocarditis Are Specific: Analysis of 100 Patients with Acute Fever or Fever of Unknown Origin. Clinical Infectious Diseases. 23(2). 298–302. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026